Liwei Dong

10PUBLICATIONS
17CO-AUTHORS
Haematological tumoursMedical biochemistry - lipidsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 13, 2025
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.

Taiyu Shang, Tianyi Jiang, Jiangqi Tan

|Feb 27, 2025
Blocking the SIRPĪ±-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice.

Yun-Kai Lin, Yu-Fei Pan, Tian-Yi Jiang

|Apr 29, 2024
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma.

Xin Li, Yu-Fei Pan, Yi-Bin Chen

|Oct 07, 2023
URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.

Zhiwen Ding, Yufei Pan, Taiyu Shang

|Jul 12, 2023
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK.

Tian-Yi Jiang, Xiao-Wen Cui, Tian-Mei Zeng

|Sep 19, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma.

Yuanyuan Shi, Xiaowen Cui, Tianyi Jiang

Pageof 2

Frequent Collaborators

6 joint publications

Hongyang Wang

4 joint publications

Yufei Pan

3 joint publications

Ye-Xiong Tan

3 joint publications

Xiaofan Feng